TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview

TuHURA Biosciences

12/08/2026 21:11

TuHURA Biosciences Inc HURA.OQ HURA.O is expected to  show no change in quarterly revenue when it reports  results on August 14 (estimated) for the period ending June 30 2026

​LSEG's mean analyst estimate for TuHURA Biosciences Inc is for a loss of 14 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for TuHURA Biosciences Inc is $8.00, about 247.8% above its last closing price of $2.30
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.12
-0.11
-0.13
Missed
-13
Dec. 31 2026
-0.13
-0.13
-0.17
Missed
-30.8
Sep. 30 2025
-0.15
-0.15
-0.13
Beat
13.3​
Jun. 30 2025
-0.14
-0.13
-0.21
Missed
-65.8
​​Mar. 31 2025
-0.10
-0.15
Missed
-50
​
This summary was machine generated August 12 at 20:11 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)